SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 1,149.24 |
| Enterprise Value ($M) | 907.66 |
| Book Value ($M) | 1,590.24 |
| Book Value / Share | 11.71 |
| Price / Book | 0.72 |
| NCAV ($M) | 1,259.40 |
| NCAV / Share | 9.27 |
| Price / NCAV | 0.91 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.36 |
| Return on Assets (ROA) | -0.23 |
| Return on Equity (ROE) | -0.31 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.05 |
| Current Ratio | 9.05 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,588.23 |
| Assets | 1,919.06 |
| Liabilities | 328.82 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 86.18 |
| Operating Income | -684.30 |
| Net Income | -615.06 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -778.78 |
| Cash from Investing | 164.63 |
| Cash from Financing | 7.48 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 9.14 | 21.82 | |
| 13G/A | Sb Investment Advisers (uk) Ltd | 12.40 | ||
| 13G | State Street Corp | 5.14 | ||
| 13G/A | BlackRock Inc. | 12.50 | 19.30 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 164,660 | 1,278,759 | 12.88 | |
| 101,230 | 548,999 | 18.44 | |
| 55,074 | 328,536 | 16.76 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| UTHR – United Therapeutics Corporation | VERV – Verve Therapeutics, Inc. |
| VIGL – Vigil Neuroscience, Inc. | VIRX – Viracta Therapeutics, Inc. |
| VOR – Vor Biopharma Inc. |
Financial data and stock pages provided by
Fintel.io